2m 2m 2m 2m 2m 2m 2m
Viatris (VTRS)
NASDAQ
$17.61+$0.05 (+0.28%)
Price as of Aug 03, 2026 4:29 AM EDT- $20.4BMarket Cap
- 107.17%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Viatris (VTRS)
$17.61+$0.05 (+0.28%)
VTRS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.56 | ||
Change | -$0.20 (-1.13%) | ||
Open | $17.65 | ||
High | $17.69 | ||
Low | $17.38 | ||
Previous Close | $17.76 | ||
Volume | 15,567,200 | ||
30-Day Average Volume | 9,497,350 | ||
1-Week Change | 1.86% | ||
1-Month Change | 10.58% | ||
1-Year Change | 107.17% | ||
3-Year Change | 89.79% | ||
5-Year Change | 54.02% | ||
Fundamentals | |||
Shares Outstanding | 1.2B | ||
Total Assets | $36.8B | ||
Market Cap | $20.4B | ||
Enterprise Value | $33.0B | ||
Period: QTR TTM FY | |||
Revenue | $3.5B | ||
Net Income | $176.4M | ||
Free Cash Flow | $348.4M | ||
EBIT | -$127.2M | ||
EBITDA | $548.9M | ||
Net Working Capital | $4.1B | ||
EPS | $0.15 | ||
Enterprise Value/EBITDA | 60 | ||
Enterprise Value/Revenue | 9 | ||
P/B | 1 | ||
P/E | 117 | ||
PEG | 1 | ||
Price/Free Cash Flow | 59 | ||
Price/Operating Cash Flow | 53 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.73% | ||
Trailing Annual Dividend Yield | 2.73% | ||
Ex-Dividend Date | 05/22/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield